|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/12/17 | Vernalis : AGM Statement | PU |
| 14/12/17 | Vernalis PLC: AGM Statement | MW |
| 13/12/17 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/12/17 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/12/17 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 04/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 31/10/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 31/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.65% | - | - | 0 | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| +0.46% | -1.16% | +23.36% | +79.34% | 58.81B | |
| +0.17% | +0.35% | +6.85% | +34.55% | 48.45B | |
| +0.73% | -2.43% | +330.06% | +686.34% | 42.84B | |
| -0.60% | -4.14% | +28.31% | +29.16% | 42.79B | |
| +0.10% | -0.82% | +6.24% | +110.05% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -0.35% | -2.64% | -9.77% | -12.45% | 24.05B | |
| Average | +0.26% | -0.25% | +53.18% | +122.23% | 43.81B | |
| Weighted average by Cap. | +0.72% | -0.54% | +56.08% | +128.58% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
